4 reasons your marijuana investment could end in tears

Marijuana stocks are high-risk plays that could disappoint investors

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There's no doubt the so-called pot stocks have been among the biggest stars of the ASX in recent times.

Stemcell United Ltd (ASX: SCU) rocketed up more than 3,000% in just one day, and those lucky enough to buy early and sell with the share price over the $1.00 mark have done well. Unfortunately, those buying at $1.00 have seen the share price smashed back to just 24.5 cents.

MMJ Phytotech Ltd (ASX: MMJ), Creso Pharma Ltd (ASX: CPH) have also seen their share prices jump more than 20% in just one day. For many investors expecting a 10% return on their holdings over a full year, that's like Christmas come early.

MGC Pharmaceuticals Ltd (ASX: MXC) and Zelda Therapeutics Ltd (ASX: ZLD) are more than doubled in the past month alone, while Auscann Group Holdings Ltd (ASX: AC8) is up 200%.

There's certainly plenty of potential for the marijuana hopefuls. Medicinal marijuana is tipped to be a huge new market, offering new types of pain relief to those patients who either can't take the usual pain medications or those that find normal pain killers just don't work for them. There's also the legal marijuana market, with some states in the US fully legalising the drug and Canada expected to legalise it this year. According to some sources, the Canadian legal weed market is worth between C$15 and C25 billion a year.

Despite the potential, you won't find me investing in these pot stocks. Here's why.

Excessive valuations

All the ASX-listed pot stocks have very little or zero in the way of revenues or sales so far. Then they need to take off their costs. Whether any of them will be profitable is another thing entirely. Share prices can be extremely volatile so how do investors know what they are worth without earnings, and whether they should buy or sell?

Uncertain winners

There's a Warren Buffett story that nicely encapsulates what's going on with the marijuana market today.

Back in 1999, when talking about the tech bubble, Buffett asked his audience to imagine investing in cars in 1910. It was evident the sector was going to be a winner. But with hundreds of auto manufacturers, which one should they choose?

It was much easier to look at it from a different perspective. Instead of going long cars, the obvious trade was to short horses.

The same principle applies today. Even resources explorer Queensland Bauxite Ltd (ASX: QBL) is entering the marijuana sector, but does that mean the company will be one of the winners?

Politics

While Canada is expected to legalise recreational use of marijuana this year, there's no certainty that the country will do that. And even if it does, there's no guarantee that Canada could turn around and reverse its decision. That could effectively make Australian pot stocks worth zero. Australia may follow suit and legalise marijuana, but that may not happen for many years. How long can these companies survive if they can't sell any product?

Safer bets

Given the huge risks, there are better ways of investing your capital in stocks that already produce profits, pay dividends and continue to grow earnings like these stocks below. While your fellow investors may have gone the boring route with lower-risk stocks, losing out big time with high-risk plays like these could see many investors leave the share market altogether.

Motley Fool writer/analyst Mike King doesn't own shares in any companies mentioned. You can follow Mike on Twitter @TMFKinga The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »